4//SEC Filing
Lee Tien-Li 4
Accession 0001193125-25-192747
CIK 0001774857other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:05 PM ET
Size
7.6 KB
Accession
0001193125-25-192747
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2025-08-28$4.24/sh+17,209$72,966→ 1,513,384 total - Exercise/Conversion
Stock option (right to buy)
2025-08-28−17,209→ 41,795 totalExercise: $4.24Exp: 2034-07-20→ Common Stock (17,209 underlying)
Holdings
- 1,474,028(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0001940120
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:05 PM ET
- Size
- 7.6 KB